• Home
  • NEW DAY MEDICINE
  • 2 (30) 2020
  • 129 -2 (30/3) 2020 — Pulatova G.A., Yusupbaev R.B., — ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF NONIMMUNE HYDROPS FETALIS

129 -2 (30/3) 2020 — Pulatova G.A., Yusupbaev R.B., — ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF NONIMMUNE HYDROPS FETALIS

ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF NONIMMUNE HYDROPS FETALIS

Pulatova G.A., – Republican specialized scientific and practical medical center of obstetrics and gynecology Tashkent, Uzbekistan 100124, Tashkent, Mirzo-Ulugbek district, Mirzo-Ulugbek St., 132-a.

Yusupbaev R.B.,- Republican specialized scientific and practical medical center of obstetrics and gynecology Tashkent, Uzbekistan 100124, Tashkent, Mirzo-Ulugbek district, Mirzo-Ulugbek St., 132-a.

Resume,

Despite of numerous advances in the diagnosis and treatment of diseases in the perinatal period, non-immune hydrops fetalis currently remains relevant and plays a significant role in the structure of perinatal morbidity and mortality. A particular problem in the practical work of obstetricians-gynecologists in identifying the early signs of non- immune hydrops fetalis caused by parvovirus B19 is the lack of a classic picture and in half of cases the asymptomatic course of the disease in pregnant women. This article provides up-to-date detailed information on various aspects of the problem of non-immune hydrops fetalis caused by parvovirus B19. Based on the analysis of literature data, etiology, epidemiology, clinical manifestations, diagnosis and treatment of the disease are described. The focus is on the adverse effects of parvovirus B19 on the fetus.

Keywords: role of parvovirus b19, the development of no immune hydro’s fatalism, modern methods of research and treatment.

First page

490

Last page

495

For citation: Pulatova G.A., Yusupbaev R.B., Role of parvovirus b19 in the development of nonimmune hydrops fetalis//New Day in Medicine 2(30)2020 490-495 https://cutt.ly/KvIBlGs

List of References

  1. Колобов А.В., Карев В.Е., Воробцова И.Н. Орлл В.И. Журнал Иифектологии. 2013; 5(2): 109-111.
  2. Курцер М.А. неиммунная водянка плода: диапюстика и так­тика // Акушерство и гинекология. 2009; 2: 37-40.
  3. Матвеев В.А. Клинико-лабораторная характеристика В19 парвовирусной инфекции // Инфекциочые болезни. 2008; 6(3): 33-37.
  4. Островская О.В. Внутриутробные инфекции. кличко-мор­фологическая оцеча совремечой специфической диапюс- тики: /Дисс. докт. мед. наук: 14.00.09. 03.00.06 // Хабаровск: ГОУ ВПО ДВГМУ Росздраваб -2009; 319.
  5. Филатова Е.В. Определече маркеров парвовируса В19 в кро­ви доноров // Журн микробиологии. 2010; 5: 67-70.
  6. ЦвиркунО.В. Клинико-эпидемиологические особечости вспышки инфекционной эритемы // Эпидемиология и вакцичпрофилактика. 2005; 2: 21-25.
  7. Allander T. Cloning of a human parvovirus by molecular screening of respiratory tract samples // Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 12891- 12896.
  8. Anderson M.J. Experimental parvoviral infection in humans // Infect. Dis. -1985; 152: 257-265.
  9. Aubrey Milunsky. Jeff Milunsky. Genetic Disorders and the Fetus Diagnosis. Prevention and Treatment. 2016; 7: 942-976.
  10. Ballou W.R. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C // Infect. Dis. 2003; 187: 675-678.
  11. Beersma M.F. Claas E.C. Sopaheluakan T. Kroes A.C. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples // Clin. Virol. 2005; 34(1): 71-75.
  12. Bellini C. Hennekam R.C. Non-immune hydrops fetalis: a short review of etiology and pathophysiology //Am J Med Genet A. – 2012; 158(3): 597-605.
  13. Beth M. Kline-Fath.. Dorothy I. Bulas. Ray Bahado-Singh. Fundamental and advanced fetal imaging: ultrasound and MRI 2015; 803-822.
  14. Bidyut Kumar. Zarko Alfi revic. Fetal medicine. 2016; 201-216.
  15. Bonvicini F. Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis // Clinical. Microbiol. 2011; 49(10): 3514-3518.
  16. Braun T. Brauer M. Fuchs I. Czernik C. Dudenhausen J.W. Heinrich W. Sarioglu N. Mirror syndrome: a systematic review of fetal associated conditions. Maternal presentation and perinatal outcome// Fetal Diagn Ther. 2010; 27(4): 191-203.
  17. Broliden K. Detection of parvovirus B19. Cytomegalovirus and enterovirus infections in cases of intrauterine fetal death // Perinat. Med. 2004; 32(6): 516-521.
  18. Brown T. Anand A. Ritchie L.D. Clewley J.P. Reid T.M.Intrauterine parvovirus infection associated with hydrops fetalis // Lancet 1984; 2: 1033.
  19. Cossart Y.E. Field A.M. Cant B. Widdows D. Parvovirus_like particles in human sera // Lancet. -1975; 72-73.
  20. De Jong E.P. de Haan T.R. Kroes A.C. Beersma M.F. Oepkes D. Walther F.J. Parvovirus B19 infection in pregnancy // Clin. Virol 2006; 36(1): 1-7.

file

download